Skip to content

Objective home-based bradykinesia assessment in Parkinson*s disease - a pilot study

Objective home-based bradykinesia assessment in Parkinson*s disease - a pilot study - Objective bradykinesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44312
Enrollment
60
Registered
2018-06-12
Start date
2018-08-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's

Interventions

None listed

Sponsors

IQ healthcare
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for Parkinson's disease and Cerebellar Ataxia only: (1) confirmed idiopathic Parkinson's Disease or Cerebellar Ataxia and (2) presence of slowness of movement. Inclusion criteria for all participants are: (1) usage of a computer with a QWERTY keyboard; (2) 18 years or older at the time of the recruitment; (3) no signs of depression or cognitive impairment; (4) no untreated hearing, visual or upper limb impairment; and (5) ability to provide written informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria for healthy elderly is: self-reported history of neurologic disease. For Parkinson's disease and Cerebellar Ataxic patients exclusion criteria are: self-reported incapacitating tremor, dystonia or dyskinesia, and an irregular medication intake scheme.

Design outcomes

Primary

MeasureTime frame
The analyses of the usual typing behaviour will provide two outcomes: typing cadence and inconsistence in typing cadence. Discriminative function analysis will evaluate the predictive power of the free typing behaviour to distinguish between Parkinson's Disease patients, Ataxic patients and healthy controls. Correlations between 1 - typing cadence or 2 - inconsistence in typing cadence with validated assessments will be used to determine the validity of typing cadence in determining the severity of bradykinesia in akinetic patients.

Secondary

MeasureTime frame
This study has one secondary study parameter: the sequence effect. The sequence effect will be expressed by the sum of keys pressed by the most affected hand per each second of the test. Sequence effect in the dominant hand will also be investigated. Furthermore, sequence effect will also be calculated from the video recording. The intensity of sound will be used to calculate amplitude and frequency of movement.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)